• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday

    8/4/22 5:54:33 AM ET
    $AAWW
    $AHG
    $AIZ
    $ALNY
    Transportation Services
    Consumer Discretionary
    Real Estate
    Real Estate
    Get the next $AAWW alert in real time by email

    Gainers

    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.
    • ECMOHO Limited (NASDAQ:MOHO) jumped 146.1% to settle at $0.4085 on above-average volume.
    • Helius Medical Technologies, Inc. (NASDAQ:HSDT) shares climbed 145.3% to close at $1.58 on Wednesday after dropping 13% on Tuesday.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) jumped 140.3% to close at $6.20.
    • Enveric Biosciences, Inc. (NASDAQ:ENVB) gained 106% to settle at $13.10. Enveric Biosciences recently announced an $8 million registered direct offering and private placement.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) jumped 89.6% to close at $3.28.
    • Poseida Therapeutics, Inc. (NASDAQ:PSTX) shares surged 85.6% to close at $4.51 as the company entered into a strategic collaboration and license agreement with Roche Holdings AG, focused on developing allogeneic CAR-T therapies directed to hematologic malignancies.
    • Eargo, Inc. (NASDAQ:EAR) shares gained 75.6% to settle at $1.23. The company is scheduled to report Q2 earnings on Monday, August 8.
    • Winc, Inc. (NYSE:WBEV) rose 71.4% to close at $2.16.
    • Cuentas Inc. (NASDAQ:CUEN) gained 70.1% to close at $0.9014. Shares of several companies in the broader communications, entertainment and media industry traded higher amid strength in the overall market and positive overall market sentiment following recent earnings.
    • Ping Identity Holding Corp. (NYSE:PING) shares jumped 60.7% to close at $28.08 after the company announced it will be acquired by Thoma Bravo for $28.50 per share in cash. Ping Identity also posted a Q2 loss of $0.34 per share.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) gained 58.7% to settle at $1.00.
    • Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) surged 49.3% to settle at $212.01 after the company announced the results from its APOLLO-B Phase 3 study of patisiran met the primary endpoint and also met the first secondary endpoint.
    • MediaCo Holding Inc. (NASDAQ:MDIA) jumped 49.1% to settle at $5.65 after climbing around 14% on Tuesday. Standard General recently purchased roughly 12.9 million shares, bringing ownership to 92.4%.
    • Otonomy, Inc. (NASDAQ:OTIC) gained 48.4% to close at $0.37. Otonomy recently announced it will discontinue development of OTO-313 after the Phase 2 trial of OTO-313 in patients with tinnitus demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints.
    • Applied DNA Sciences, Inc. (NASDAQ:APDN) jumped 46.4% to close at $4.10 on continued strength after the company initiated analytical validation of a Company-developed, PCR-based monkeypox virus test that is specific for the genetic signature of the monkeypox virus.
    • NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) gained 45.8% to close at $1.75 after the company announced a $3.5 million accelerated milestone payment from Zimmer Biomet. The amendment will also provide Zimmer with 350,000 warrants with an exercise price of $3.00 per share.
    • Chembio Diagnostics, Inc. (NASDAQ:CEMI) shares rose 42.5% to close at $1.04. Chembio Diagnostics is expected to release financial results for the second quarter after the close of trading on Thursday, August 4, 2022.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) rose 38.3% to close at $0.2450 after the company entered into an equity purchase agreement with Lincoln Park Capital for up to $20 million.
    • Akso Health Group (NASDAQ:AHG) jumped 37.6% to close at $1.30.
    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) gained 35.2% to settle at $1.46. Shares of several companies in the broader consumer discretionary sector traded higher amid overall market strength.
    • Lottery.com Inc. (NASDAQ:LTRY) jumped 34.3% to settle at $0.4701.
    • Brickell Biotech, Inc. (NASDAQ:BBI) gained 33% to close at $4.19.
    • Tupperware Brands Corporation (NYSE:TUP) surged 32.4% to close at $9.53 after the company reported better-than-expected Q2 results.
    • Senseonics Holdings, Inc. (NYSE:SENS) gained 31.5% to settle at $1.67.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) climbed 31.4% to close at $1.55.
    • Leju Holdings Limited (NYSE:LEJU) gained 28.5% to settle at $2.9931.
    • SoFi Technologies, Inc. (NASDAQ:SOFI) climbed 28.4% to close at $8.23 after the company reported better-than-expected Q2 results and raised FY22 guidance.
    • Endo International plc (NASDAQ:ENDP) rose 28.1% to settle at $0.7481.
    • Avalon GloboCare Corp. (NASDAQ:AVCO) gained 28% to close at $0.6450.
    • Locafy Limited (NASDAQ:LCFY) jumped 27.8% to close at $0.5945.
    • Exicure, Inc. (NASDAQ:XCUR) gained 26.8% to settle at $1.99.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) gained 26.5% to close at $48.94.
    • GreenLight Biosciences Holdings (NASDAQ:GRNA) jumped 25.4% to settle at $3.26. Samsung Biologics and the company recently announced the completion of the first commercial-scale engineering run for the companies' mRNA production partnership.
    • MSP Recovery, Inc. (NASDAQ:MSPR) rose 24.8% to close at $2.06.
    • Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) gained 23.7% to settle at $17.53. Morgan Stanley maintained Rhythm Pharmaceuticals with an Equal-Weight and raised the price target from $8 to $16.
    • Community Health Systems, Inc. (NYSE:CYH) rose 22.8% to close at $3.50. Community Health Systems Executive Chairman Wayne T Smith acquired a total of 1,000,000 shares at an average price of $2.95.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) gained 22.7% to settle at $2.97. The company on Tuesday announced a financing agreement with FF Top Holding LLC and provided a manufacturing update.
    • Q&K International Group Limited (NASDAQ:QK) jumped 21.8% to close at $2.29.
    • PolarityTE, Inc. (NASDAQ:PTE) rose 21% to settle at $1.67.
    • Nova LifeStyle, Inc. (NASDAQ:NVFY) gained 20.6% to settle at $0.95.
    • Coinbase Global, Inc. (NASDAQ:COIN) jumped 20.2% to close at $80.81.
    • MeiraGTx Holdings plc (NASDAQ:MGTX) rose 19.7% to settle at $9.35 as the company reported financing agreement with Perceptive Advisors for up to $100 million secured by manufacturing facilities.
    • Clearwater Paper Corporation (NYSE:CLW) gained 19.3% to close at $41.51 following strong quarterly sales.
    • Tuniu Corporation (NASDAQ:TOUR) shares gained 19.2% to close at $0.9610 after dropping over 9% on Tuesday.
    • Alteryx, Inc. (NYSE:AYX) climbed 19% to close at $60.20 following strong Q2 results.
    • Semler Scientific, Inc. (NASDAQ:SMLR) jumped 18.8% to settle at $39.50 after the company reported Q2 earnings results.
    • Asia Pacific Wire & Cable Corporation Limited (NASDAQ:APWC) gained 17.8% to close at $1.39.
    • Donnelley Financial Solutions, Inc. (NASDAQ:DFIN) climbed 17.8% to close at $39.57 after the company reported better-than-expected Q2 results.
    • Generation Bio Co. (NASDAQ:GBIO) climbed 17.6% to close at $7.50.
    • Moderna, Inc. (NASDAQ:MRNA) jumped 16% to close at $186.49 after the company reported better-than-expected Q2 EPS and sales results and announced a $3 billion buyback.
    • Unum Group (NYSE:UNM) gained 14.6% to settle at $35.93 after the company reported better-than-expected Q2 EPS and sales results.
    • Upstart Holdings, Inc. (NASDAQ:UPST) gained 14.2% to close at $29.06.
    • NeuroMetrix, Inc. (NASDAQ:NURO) gained 14.2% to close at $4.10. NeuroMetrix recently posted a Q2 loss of $0.17 per share.
    • Passage Bio, Inc. (NASDAQ:PASG) rose 14.1% to close at $2.11. Passage Bio is expected to report Q2 financial results on August 4, 2022.
    • Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) gained 13.9% to close at $22.21. Arcutis Biotherapeutics priced its 7.5 million share public offering of common stock at $20 per share.
    • Herbalife Nutrition Ltd. (NYSE:HLF) jumped 13.6% to close at $27.50 following Q2 results.
    • Sprout Social, Inc. (NASDAQ:SPT) gained 13.3% to settle at $58.91 after the company reported better-than-expected Q2 EPS and sales results.
    • Camping World Holdings, Inc. (NYSE:CWH) gained 12.5% to close at $29.84 after the company reported better-than-expected Q2 EPS and sales results.
    • Wayfair Inc. (NYSE:W) gained 12.2% to settle at $64.44.
    • Asana, Inc. (NYSE:ASAN) surged 12.2% to close at $23.14.
    • Robinhood Markets, Inc. (NASDAQ:HOOD) jumped 11.7% to settle at $10.31 after the company reported better-than-expected Q2 EPS results.
    • Block, Inc. (NYSE:SQ) rose 11.4% to close at $88.07 ahead of quarterly earnings, scheduled for release today.
    • SemiLEDs Corporation (NASDAQ:LEDS) rose 11.4% to close at $3.62.
    • Aspira Women's Health Inc. (NASDAQ:AWH) climbed 11.2% to settle at $0.9040.
    • Shopify Inc. (NYSE:SHOP) rose 11.1% to close at $41.93.
    • Atlas Air Worldwide Holdings, Inc. (NASDAQ:AAWW) gained 10.8% to close at $96.78 following a Monday Wall Street Journal report suggesting Apollo Global Management was in advanced talks to acquire the company. Additionally, Wolfe Research upgraded the stock from Underperform to Peer Perform.
    • Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) rose 10.3% to close at $41.02. Ionis Pharmaceuticals recently announced positive topline results of the Phase 2b clinical trial of fesomersen in patients with end-stage renal disease (ESRD) on hemodialysis.
    • Coupa Software Incorporated (NASDAQ:COUP) gained 9.9% to close at $75.36.
    • PayPal Holdings, Inc. (NASDAQ:PYPL) rose 9.3% to close at $97.92 after the company reported better-than-expected Q2 results and raised FY22 EPS guidance.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) gained 8.2% to close at $0.7403.

     

    Losers

    • AMTD Digital Inc. (NYSE:HKD) dipped 34.5% to settle at $1,100.00 on Wednesday.
    • MMTec, Inc. (NASDAQ:MTC) fell 34.4% to close at $5.15 after jumping over 390% on Tuesday. MMTEC recently regained compliance with NASDAQ minimum bid price requirement.
    • Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPB) fell 34.2% to close at $38.00 after climbing around 23% on Tuesday.
    • Ampio Pharmaceuticals, Inc. (NYSE:AMPE) dropped 33.8% to close at $0.1034. Ampio said Special Committee's findings include former Ampio Executive Officers, Senior Staff did not fully report results of Ap-013 trial, timing of unblinding of data from AP-013 trial.
    • Alpha Capital Acquisition Company (NASDAQ:ASPC) fell 31.5% to close at $6.95. Alpha Capital Acquisition Company’s shareholders approved proposed merger transaction with Semantix.
    • Intelligent Living Application Group Inc. (NASDAQ:ILAG) dropped 30.3% to close at $2.32.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) fell 29.3% to close at $5.00 after gaining around 39% on Tuesday. Meihua International Medical Technologies recently reported FY21 sales were up year over year.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) shares fell 28% to close at $6.21 after dropping around 33% on Tuesday.
    • CHW Acquisition Corporation (NASDAQ:CHWA) dropped 27.1% to close at $8.00.
    • MDJM Ltd (NASDAQ:MDJH) shares fell 26.7% to close at $2.50 after surging 90% on Tuesday.
    • Zovio Inc (NASDAQ:ZVO) fell 24.7% to close at $0.4291.
    • L&F Acquisition Corp. (NYSE:LNFA) dipped 24% to close at $10.95.
    • Orion Energy Systems, Inc. (NASDAQ:OESX) fell 23.8% to close at $1.76 after the company reported worse-than-expected Q1 EPS and sales results.
    • Nano Labs Ltd (NASDAQ:NA) fell 22.3% to close at $7.15 amid post-IPO volatility after the stock opened for trade last month.
    • Infinera Corporation (NASDAQ:INFN) dropped 20.8% to close at $5.13. The company recently posted upbeat quarterly results.
    • SolarEdge Technologies, Inc. (NASDAQ:SEDG) fell 19.1% to close at $295.52 after the company reported worse-than-expected Q2 EPS.
    • Rocky Brands, Inc. (NASDAQ:RCKY) fell 19% to close at $27.51 after the company reported worse-than-expected Q2 EPS results.
    • Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) fell 18.5% to close at $66.96 after the company reported worse-than-expected Q2 EPS and sales results and lowered FY22 sales guidance below estimates.
    • Match Group, Inc. (NASDAQ:MTCH) fell 17.6% to close at $63.24 after the company reported worse-than-expected Q2 sales and guided for muted top-line growth in the second half of 2022.
    • MAIA Biotechnology, Inc. (NASDAQ:MAIA) fell 17.4% to close at $5.36 after dipping around 17% on Tuesday. Maia Biotechnology received FDA Orphan Drug Designation for THIO for the treatment of small-cell lung cancer.
    • Apexigen Inc. (NASDAQ:APGN) declined 16.7% to settle at $11.52.
    • VAALCO Energy, Inc. (NYSE:EGY) dropped 16% to settle at $4.82.
    • Boqii Holding Limited (NYSE:BQ) dipped 14.9% to close at $2.29.
    • Viemed Healthcare, Inc. (NASDAQ:VMD) dropped 14.2% to close at $6.83 following Q2 results.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) fell 14.1% to close at $2.92 after jumping 63% on Tuesday.
    • OKYO Pharma Limited (NASDAQ:OKYO) dropped 13.7% to settle at $1.96.
    • Mercury Systems, Inc. (NASDAQ:MRCY) dropped 13.3% to close at $49.81 after the company reported worse-than-expected Q4 EPS and sales results. The company also issued Q1 EPS and sales guidance below analyst estimates.
    • Southwest Gas Holdings, Inc. (NYSE:SWX) fell 13.1% to settle at $75.85. Southwest Gas board concluded its strategic review.
    • Knowles Corporation (NYSE:KN) fell 12.9% to close at $16.61 after reporting downbeat quarterly sales. Roth Capital downgraded Knowles from Buy to Neutral and lowered the price target from $30 to $17.
    • Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) shares fell 12.8% to close at $2.85 after the company issued weak sales forecast for the second quarter. JP Morgan downgraded Hydrofarm from Overweight to Neutral.
    • Triumph Group, Inc. (NYSE:TGI) dropped 12.8% to close at $14.47 after the company issued weak earnings forecast for FY23.
    • Owens & Minor, Inc. (NYSE:OMI) fell 11.5% to close at $32.42 after reporting downbeat quarterly sales. Owens & Minor expects sales of $9.8 billion - $10.1 billion (prior view $9.9 billion - $10.3 billion) versus the consensus of $10.15 billion.
    • Assurant, Inc. (NYSE:AIZ) dipped 10.2% to close at $154.10 following downbeat quarterly earnings.
    • Molecular Data Inc. (NASDAQ:MKD) fell 6.3% to close at $0.61 following Q2 results.
    • Big 5 Sporting Goods Corporation (NASDAQ:BGFV) fell 5.4% to close at $12.16 after reporting weak Q2 results.
    Get the next $AAWW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAWW
    $AHG
    $AIZ
    $ALNY

    CompanyDatePrice TargetRatingAnalyst
    Upstart Holdings Inc.
    $UPST
    2/13/2026$20.00Mkt Perform → Mkt Underperform
    Citizens
    Upstart Holdings Inc.
    $UPST
    2/13/2026$35.00Sell → Neutral
    Goldman
    Coinbase Global Inc.
    $COIN
    2/12/2026$120.00Buy → Neutral
    Monness Crespi & Hardt
    Shopify Inc.
    $SHOP
    2/12/2026$150.00Neutral → Outperform
    Mizuho
    Shopify Inc.
    $SHOP
    2/12/2026$159.00Hold → Buy
    TD Cowen
    Robinhood Markets Inc.
    $HOOD
    2/11/2026$135.00 → $100.00Buy
    Needham
    Shopify Inc.
    $SHOP
    2/10/2026$150.00Neutral → Buy
    MoffettNathanson
    PayPal Holdings Inc.
    $PYPL
    2/10/2026$58.00 → $39.00Sell
    Truist
    More analyst ratings

    $AAWW
    $AHG
    $AIZ
    $ALNY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Upstart downgraded by Citizens with a new price target

    Citizens downgraded Upstart from Mkt Perform to Mkt Underperform and set a new price target of $20.00

    2/13/26 8:31:11 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Upstart upgraded by Goldman with a new price target

    Goldman upgraded Upstart from Sell to Neutral and set a new price target of $35.00

    2/13/26 8:26:40 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Coinbase Global downgraded by Monness Crespi & Hardt with a new price target

    Monness Crespi & Hardt downgraded Coinbase Global from Buy to Neutral and set a new price target of $120.00

    2/12/26 7:44:13 AM ET
    $COIN
    Finance: Consumer Services
    Finance

    $AAWW
    $AHG
    $AIZ
    $ALNY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Solana Company (NASDAQ: HSDT) Becomes First Digital Asset Treasury to Enable Borrowing Against Natively Staked SOL in Qualified Custody

    Solana Company (HSDT), Anchorage Digital, and Kamino collaborate to bring institutional capital to Solana's high-performance DeFi ecosystem through a first-of-its-kind tri-party custody model Institutions earn staking rewards while accessing on-chain liquidity—24/7 automated collateral management enables real-time borrowing operations without sacrificing custody, compliance, or operational control Scalable model designed to provide a blueprint for other treasury companies and what institutional investors will demand NEWTOWN, Pa., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ:HSDT or the "Company"), together with Anchorage Digital and Kamino, today launched the first-ever digi

    2/13/26 9:00:00 AM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    American Rebel Light Beer and Wil Fischer Distributing Forge Powerful Missouri Partnership to Expand Distribution Footprint

    Wil Fischer's 50+ year legacy as a top Anheuser-Busch distributor will supercharge American Rebel Light Beer's expansion in Missouri. Wil Fischer Distributing adds a multi-region territory of nearly 900,000 residents and planned 2026 brand reach opportunities for American Rebel Light Beer through the iconic 9,000-seat Black Oak Amphitheater. NASHVILLE, TN, Feb. 13, 2026 (GLOBE NEWSWIRE) -- American Rebel Beverages, a subsidiary of American Rebel Holdings, Inc. (NASDAQ:AREB), today announced a new distribution agreement with Wil Fischer Distributing, one of Missouri's largest and most respected Anheuser-Busch wholesalers. The partnership significantly expands American Rebel Light Beer's p

    2/13/26 8:00:00 AM ET
    $AREB
    Plastic Products
    Industrials

    OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares

    LONDON and NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ:OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced the pricing of an underwritten public offering (the "Offering") of 10,815,000 ordinary shares at an offering price of $1.85 per ordinary share. The Company has granted the underwriter a 30-day option to purchase up to an additional 1,622,250 ordinary shares at the public offering price, less underwriting discounts and commissions. The gross proceeds to the Company from the Offering, before deducting offering expenses pay

    2/12/26 10:20:03 PM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAWW
    $AHG
    $AIZ
    $ALNY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: EVP, Chief Scientific Officer Bennett C Frank disposed of 0 shares (SEC Form 4)

    4/A - IONIS PHARMACEUTICALS INC (0000874015) (Issuer)

    2/13/26 7:40:36 PM ET
    $IONS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP Research Swayze Eric sold $1,278,914 worth of shares (15,642 units at $81.76), decreasing direct ownership by 33% to 32,105 units (SEC Form 4)

    4 - IONIS PHARMACEUTICALS INC (0000874015) (Issuer)

    2/13/26 7:40:24 PM ET
    $IONS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Parshall B Lynne sold $413,588 worth of shares (5,000 units at $82.72), decreasing direct ownership by 8% to 56,344 units (SEC Form 4)

    4 - IONIS PHARMACEUTICALS INC (0000874015) (Issuer)

    2/13/26 7:40:10 PM ET
    $IONS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAWW
    $AHG
    $AIZ
    $ALNY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel Lavet Robert S bought $105,220 worth of shares (5,000 units at $21.04) (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/6/26 6:18:51 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    EVP GBUL Borrow Schuppenhauer Eric bought $99,650 worth of shares (5,000 units at $19.93), increasing direct ownership by 2% to 228,768 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/5/26 5:53:28 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    CEO Barretto Ryan Paul bought $1,002,621 worth of shares (93,984 units at $10.67), increasing direct ownership by 12% to 875,256 units (SEC Form 4)

    4 - Sprout Social, Inc. (0001517375) (Issuer)

    1/13/26 4:01:19 PM ET
    $SPT
    Computer Software: Prepackaged Software
    Technology

    $AAWW
    $AHG
    $AIZ
    $ALNY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for GIVLAARI issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug GIVLAARI (SUPPL-7) with active ingredient GIVOSIRAN SODIUM has changed to 'Approval' on 04/29/2024. Application Category: NDA, Application Number: 212194, Application Classification: Labeling

    4/30/24 1:44:03 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZORYVE issued to ARCUTIS BIOTHERAPEUTICS INC

    Submission status for ARCUTIS BIOTHERAPEUTICS INC's drug ZORYVE (ORIG-1) with active ingredient ROFLUMILAST has changed to 'Approval' on 12/15/2023. Application Category: NDA, Application Number: 217242, Application Classification: Type 3 - New Dosage Form

    12/19/23 3:40:08 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZORYVE issued to ARCUTIS BIOTHERAPEUTICS INC

    Submission status for ARCUTIS BIOTHERAPEUTICS INC's drug ZORYVE (ORIG-1) with active ingredient ROFLUMILAST has changed to 'Approval' on 12/15/2023. Application Category: NDA, Application Number: 217242, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    12/15/23 5:01:31 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAWW
    $AHG
    $AIZ
    $ALNY
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Upstart Holdings Inc.

    SCHEDULE 13G/A - Upstart Holdings, Inc. (0001647639) (Subject)

    2/13/26 5:23:16 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Clearwater Paper Corporation

    SCHEDULE 13G/A - Clearwater Paper Corp (0001441236) (Subject)

    2/13/26 4:53:08 PM ET
    $CLW
    Paper
    Basic Materials

    Amendment: SEC Form SCHEDULE 13G/A filed by MeiraGTx Holdings plc

    SCHEDULE 13G/A - MeiraGTx Holdings plc (0001735438) (Subject)

    2/13/26 4:31:54 PM ET
    $MGTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAWW
    $AHG
    $AIZ
    $ALNY
    Financials

    Live finance-specific insights

    View All

    VAALCO Energy, Inc. Announces Participation in Non-Deal Roadshow and Updated Investor Presentation

    HOUSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE:EGY, LSE: EGY)) ("Vaalco" or the "Company") announced that it will be participating in non-deal road show meetings with prospective investors in Edinburgh, Scotland on February 13th. The Company has posted an updated investor presentation to its website. The presentation is made available at the following link: (https://www.vaalco.com/investors/news-events/presentations) Highlights: Key updates on the Baobab Ivoirien refurbishment project, including completion of the dry dock work previously referred to in the Company's Third Quarter 2025 Results released in NovemberStrategic positioning through asset divestiture of its

    2/12/26 5:00:00 PM ET
    $EGY
    Oil & Gas Production
    Energy

    Coinbase Delivers on Q4 Financial Outlook, Doubles Total Trading Volume and Crypto Trading Volume Market Share in 2025

    All-time high Coinbase Total Trading Volume, up 156% Y/Y, outperforming the market All-time high Coinbase Crypto Trading Volume Market Share up 103% Y/Y All-time high Subscription and Services Revenue in 2025 All-time high Paid Coinbase One Subscribers in 2025, up 3x in 3 years Coinbase Global, Inc. (NASDAQ:COIN) has posted a shareholder letter containing its financial results for the fourth quarter and full year ended December 31, 2025 on its Investor Relations website at investor.coinbase.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212063960/en/ All Q4 financial results were within expected ranges, reflectin

    2/12/26 4:09:00 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress

    − Achieved Fourth Quarter and Full Year 2025 Global Net Product Revenues of $995 Million and $2,987 Million, Respectively, Representing 121% and 81% Growth Compared to Same Periods in 2024 – − Attained GAAP and non-GAAP Profitability for Full Year 2025, with Sustainable Growth in Operating Income Expected – − Launched "Alnylam 2030" Strategy Focused on Scaling Alnylam through Durable ATTR Leadership, Long-Term Sustainable Innovation, and Exceptional Financial Results – − Announced 2026 Pipeline Goals, Including 4 Clinical Readouts, 3 Ongoing Pivotal Studies, 3 Phase 2 Study Initiations, and 3+ New IND Filings – − Reiterates Net Product Sales Guidance and Provides Additional 2026 Fin

    2/12/26 8:00:00 AM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAWW
    $AHG
    $AIZ
    $ALNY
    Leadership Updates

    Live Leadership Updates

    View All

    OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer

    Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a blockbuster orphan therapy in corneal diseaseDr. Mantelli will lead the clinical and regulatory strategy to advance the company's development program in neuropathic corneal pain (NCP), leveraging urcosimod's FDA Fast Track designationThis appointment, following the recent CEO appointment, further strengthens OKYO's world-class ophthalmology leadership team LONDON and NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neur

    2/10/26 8:00:00 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    NodThera Appoints Geoff McDonough, M.D., as Chief Executive Officer

    Dr. McDonough brings global company-building, commercial strategy, and R&D leadership experience to the Company ahead of key clinical milestones NodThera plans to report results from two Phase 2 cardiometabolic trials RESOLVE-1 and RESOLVE-2 in mid-2026 and third quarter 2026 respectively Company preparing to begin cardiometabolic Phase 3 trial in 1H 2027 BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- NodThera, the leading clinical-stage NLRP3 company developing a portfolio of best-in-class brain-penetrant and immune-targeted oral inhibitors to address unmet needs in cardiometabolic and neuroinflammatory diseases driven by the NLRP3/IL-6/IL-1 inflammation pathway, announced the appointment o

    2/4/26 8:00:00 AM ET
    $GBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    PayPal Appoints Enrique Lores as Chief Executive Officer and David W. Dorman as Independent Board Chair

    SAN JOSE, Calif., Feb. 3, 2026 /PRNewswire/ -- PayPal Holdings Inc. (NASDAQ:PYPL) today announced that its Board of Directors has appointed Enrique Lores as President and CEO, effective March 1, 2026. Lores, who has served on the PayPal Board for nearly five years and as Board Chair since July 2024, succeeds Alex Chriss. To ensure a seamless transition, Jamie Miller, Chief Financial and Operating Officer, will serve as Interim CEO until Lores assumes the role. David W. Dorman has been appointed as Independent Board Chair, effective immediately. Today's appointment follows a de

    2/3/26 6:58:00 AM ET
    $PYPL
    Diversified Commercial Services
    Industrials

    $AAWW
    $AHG
    $AIZ
    $ALNY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

    SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

    12/12/24 4:16:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care